Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial.
Saved in:
| Title: | Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial. |
|---|---|
| Authors: | Rodriguez GD; Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States.; Columbia University School of Nursing, New York, NY, United States., Warren N; Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States., Yashayev R; Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States., Chitra S; Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States., Amodio-Groton M; Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States., Wright K; Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2023 Jul 28; Vol. 10, pp. 1225710. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
